Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Nilontinib induced keratosis pilaris atrophicans
- Dermatologic Side Effects of Psychotropic Medications
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Drug eruptions in dermatology
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Sorafenib-induced Facial Acneiform Eruption
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Dermatological adverse events with taxane chemotherapy
- Adverse Reactions to Oral Retinoids An Update
- Cutaneous reactions to recombinant cytokine therapy
- 1,314
- Therapies
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Semaglutide and the Skin: An Overview of Current Evidence
- Cutaneous drug reactions
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial
- 1. Medical Practice; Therapy; Adverse Reactions